Prime Medicine PRME Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$198.37M+1.8% | -$201.14M-2.7% | -$197.34M+10.0% | -$199.28M+8.4% | -$202.01M+1.2% | ||
| $7.48M+14.8% | $7.32M+19.5% | $7.16M+26.6% | $6.84M+28.2% | $6.51M+32.5% | ||
| $28.23M+6.4% | $29.27M+12.3% | $30.69M+25.0% | $24.77M+12.9% | $26.54M+52.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$6.56M-146% | -$4.55M-128% | $4.44M-56.2% | $12.69M+82.6% | $14.13M+28.9% | ||
| -$3.78M-105% | -$4.36M-106% | -$3.61M-105% | $69.49M— | $70.48M— | ||
| $1.49M— | $432K— | —— | —— | —— | ||
| $10.13M-11.3% | $9.7M-21.5% | $9.3M-31.1% | $9.2M-36.1% | $11.42M-14.2% | ||
| -$6.64M-82.5% | -$5.36M+17.0% | -$4.11M-4,517% | -$2.84M-51.8% | -$3.64M-5.4% | ||
| -$156.42M— | -$162.56M— | —— | —— | —— | ||
| $2.32M-68.6% | $4.53M-37.9% | $6.03M-17.9% | $7.06M-21.3% | $7.39M-18.3% | ||
| $164.38M— | $205.41M— | —— | —— | —— | ||
| —— | —— | -$114.62M-152% | -$95.75M-154% | -$69.5M-141% | ||
| —— | —— | —— | —— | $57.75M+1,121% | ||
| $393K— | $0— | —— | —— | —— | ||
| $145.91M+228% | $151.51M-22.6% | $150.95M-23.0% | $44.71M-71.7% | $44.55M-71.8% | ||
| —— | —— | —— | -$1.6M— | —— | ||
| $2.2M-14.7% | $1.94M-37.4% | $1.29M-67.9% | $1.59M-61.1% | $2.58M— | ||
| —— | —— | —— | —— | —— | ||
| -$6.64M-82.5% | -$5.36M+17.0% | -$4.11M-4,517% | -$2.84M-51.8% | -$3.64M-5.4% | ||
| -$6.56M-146% | -$4.55M-128% | $4.44M-56.2% | $12.69M+82.6% | $14.13M+28.9% | ||
| $10.13M-11.3% | $9.7M-21.5% | $9.3M-31.1% | $9.2M-36.1% | $11.42M-14.2% | ||
| —— | $0+100% | -$250K+64.7% | -$500K-20.5% | -$750K-512% | ||
| $164.38M— | $205.41M— | —— | —— | —— | ||
| $143.67M+6.7% | $95.78M-53.1% | $89.58M-59.1% | $108.45M-38.9% | $134.7M-20.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$3.78M-105% | -$4.36M-106% | -$3.61M-105% | $69.49M— | $70.48M— | ||
| -$6.64M-82.5% | -$5.36M+17.0% | -$4.11M-4,517% | -$2.84M-51.8% | -$3.64M-5.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $3.12M-31.6% | ||
| —— | $10.91M— | $8.18M— | $5.46M— | $2.73M— | ||
| -$158.74M— | -$167.1M— | —— | —— | —— | ||
| -$158.74M— | -$167.1M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Prime Medicine generate?
- Prime Medicine (PRME) generated -$156.4M in operating cash flow over the trailing twelve months.
- What is Prime Medicine's free cash flow?
- After $2.3M of capital expenditures, Prime Medicine's free cash flow was -$158.7M over the trailing twelve months, up 19.0% year over year.
- Where does Prime Medicine's cash flow data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
